Sana Biotechnology Statistics
Total Valuation
SANA has a market cap or net worth of $1.94 billion. The enterprise value is $1.73 billion.
Market Cap | 1.94B |
Enterprise Value | 1.73B |
Important Dates
The last earnings date was Wednesday, May 8, 2024, after market close.
Earnings Date | May 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SANA has 221.50 million shares outstanding. The number of shares has increased by 13.63% in one year.
Shares Outstanding | 221.50M |
Shares Change (YoY) | +13.63% |
Shares Change (QoQ) | +10.10% |
Owned by Insiders (%) | 8.63% |
Owned by Institutions (%) | 89.97% |
Float | 129.01M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 5.18 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.07, with a Debt / Equity ratio of 0.28.
Current Ratio | 6.07 |
Quick Ratio | n/a |
Debt / Equity | 0.28 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -89.20% and return on invested capital (ROIC) is -66.46%.
Return on Equity (ROE) | -89.20% |
Return on Assets (ROA) | -47.70% |
Return on Capital (ROIC) | -66.46% |
Revenue Per Employee | n/a |
Profits Per Employee | -$940,875 |
Employee Count | 328 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.71% in the last 52 weeks. The beta is 1.62, so SANA's price volatility has been higher than the market average.
Beta (1Y) | 1.62 |
52-Week Price Change | +16.71% |
50-Day Moving Average | 8.98 |
200-Day Moving Average | 6.03 |
Relative Strength Index (RSI) | 49.23 |
Average Volume (30 Days) | 1,920,388 |
Short Selling Information
The latest short interest is 25.65 million, so 11.58% of the outstanding shares have been sold short.
Short Interest | 25.65M |
Short Previous Month | 26.72M |
Short % of Shares Out | 11.58% |
Short % of Float | 19.88% |
Short Ratio (days to cover) | 17.04 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -319.81M |
Pretax Income | -308.61M |
Net Income | -308.61M |
EBITDA | -271.40M |
EBIT | -308.61M |
Earnings Per Share (EPS) | -$1.53 |
Balance Sheet
The company has $314.91 million in cash and $106.09 million in debt, giving a net cash position of $208.83 million or $0.94 per share.
Cash & Cash Equivalents | 314.91M |
Total Debt | 106.09M |
Net Cash | 208.83M |
Net Cash Per Share | $0.94 |
Equity / Book Value | 375.14M |
Book Value Per Share | 1.69 |
Working Capital | 268.36M |
Cash Flow
In the last 12 months, operating cash flow was -$239.94 million and capital expenditures -$33.70 million, giving a free cash flow of -$273.64 million.
Operating Cash Flow | -239.94M |
Capital Expenditures | -33.70M |
Free Cash Flow | -273.64M |
FCF Per Share | -$1.26 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
SANA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13.63% |
Shareholder Yield | -13.63% |
Earnings Yield | -15.89% |
FCF Yield | -14.09% |
Analyst Forecast
The average price target for SANA is $11.67, which is 33.68% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $11.67 |
Price Target Difference | 33.68% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |